In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation-Reference-Cited by-同舟云学术

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation

Published:2001-05 Issue:3 Volume:3 Page:197-201
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Kottaridis P.D.,Milligan D.W.,Chopra R.,Chakraverty R.K.,Chakrabarti S.,Robinson S.,Peggs K.,Verfuerth S.,Pettengell R.,Marsh J.C.W.,Schey S.,Mahendra P.,Morgan G.J.,Hale G.,Waldmann H.,Ruiz de Elvira M.C.,Williams C.D.,Devereux S.,Linch D.C.,Goldstone A.H.,Mackinnon S.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference20 articles.

1. Outcome after allogeneic bone marrow transplant for leukemia in older adults;Ringden;J Am Med Assoc,1993

2. Bone marrow transplantation in patients aged 45 years and older;Klingemann;Blood,1986

3. Antileukemic effect of graft versus host disease in recipients of allogeneic marrow grafts;Weiden;N Engl J Med,1979

4. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients;Kolb;Blood,1990

5. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia following bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease;Mackinnon;Blood,1995

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an “outpatient” alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-09-09

2. Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation;Cytotherapy;2021-01

3. Non‐myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies;European Journal of Haematology;2020-07-10

4. Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft;Transplant Immunology;2019-12

5. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study;Infection;2019-02-07